Probiotic CFU Counts: What They Mean and Whether More Is Better

If you are shopping for a probiotic, you have probably compared CFU counts: 10 billion, 50 billion, even 100 billion. Those numbers matter, but they are only part of the picture. CFU tells you how many live, culturable cells are in the bottle; it does not tell you whether those cells survive digestion, reach the gut in good shape, or do anything useful once they get there. This guide explains what a CFU count does and does not measure, how it compares to newer counting methods, and what else to look at when judging a probiotic, so you can read a label with a clearer eye rather than defaulting to the biggest number.

Quick Answer: What do CFU counts mean, and is more better?

CFU, or colony-forming units, is the standard way to report how many live, culturable bacteria are in a probiotic. It is a useful and necessary measure: it shows that cells were alive and able to grow at testing, and it helps confirm a product holds up through its shelf life. What it does not tell you is whether those cells survive digestion, whether the specific strain has evidence for what you want, or whether the delivery works. So a higher CFU is not automatically better. Past a sensible, studied dose, more cells do not reliably mean more benefit. The count is one input; the strain, its viability through shelf life and digestion, a dose matched to research, and the delivery format matter just as much.

What CFU Actually Measures

CFU (colony-forming units) measures the number of bacteria in a sample that can grow into visible colonies on a culture plate. It is the industry-standard viability measure, and it is genuinely useful: it confirms live cells are present, and it is how manufacturers verify a product still meets its label through storage and shelf life.

Its limits are just as real. A plate count only captures cells that readily grow under the chosen lab conditions, so it can undercount strains that are alive but slow or difficult to culture, and different strains need different growth conditions to count accurately (Davis 2014). And whatever the number, a CFU count says nothing about what happens after you swallow the capsule: survival through stomach acid and bile, interaction with the gut lining, or benefit for a particular goal. That is why "higher CFU equals better probiotic" does not hold up. Poorly delivered or poorly matched cells will not help, no matter how many there are.

CFU vs AFU: Two Ways to Count

Because plate counts miss some live cells, the industry increasingly uses culture-independent methods, and you may see a second number on some labels: AFU, or active fluorescent units. AFU comes from flow cytometry, which counts live cells directly using fluorescent stains that flag intact, metabolically active cells, rather than waiting to see which cells grow on a plate (Davis 2014).

The practical difference is that flow-cytometry counts can capture viable cells that culture methods miss, including cells in a viable-but-non-culturable state. That matters most for fastidious, hard-to-culture strains, and it is one honest reason a product with a moderate CFU can still deliver a meaningful number of live cells. Two caveats keep this grounded: a higher AFU does not prove those cells survive digestion or produce a benefit, and CFU and AFU are not interchangeable numbers, so compare like with like rather than reading a big AFU as a big CFU.

What a CFU count can and cannot tell you

Bacterial Surface and Host Interaction

A bacterium's outer surface is where it makes contact with the gut lining and the immune system, so surface molecules such as S-layer proteins, pili, and the polysaccharides around the cell are an active area of probiotic research. In laboratory and animal studies, these structures influence how well a strain adheres to the gut lining and signals to host cells, which is part of why two strains with similar cell counts can behave differently. This is best read as a reason strain identity matters, not as a consumer metric you can compare on a label. There is no simple "more surface area equals better" number, and much of this work is still mechanistic.

Delivery Format and Why It Matters

How a probiotic is delivered affects where, and in what condition, the cells arrive. Capsules are designed to release cells lower in the digestive tract, while chewable and oral formats first interact with the mouth and upper digestive tract. Each approach has trade-offs, and the honest position is that no single format is universally superior. What matters is that the format suits the strain and protects viability through to where the cells are meant to act. Next-Microbiome uses a chewable format for its Akkermansia product to support oral and upper-tract interaction, which is one design choice among several rather than a proven advantage over all capsules.

What Matters Beyond the Count

If the CFU number is only one input, what else should you weigh? A few things carry more signal than the headline count:

• Strain identity. Benefits in research are usually tied to specific strains, not just a species, so the label should name the genus, species, and strain (Hill 2014).

• Viability where it counts. What matters is live cells at the end of shelf life and after digestion, not only at manufacture, which is why storage instructions and use-by dates matter.

• A dose matched to evidence. The useful question is whether the amount reflects what was studied for that strain, not whether the number is simply large.

• Delivery and formulation. The format and any supporting ingredients should protect the cells and suit the strain.

• Evidence for your goal. A strain studied for one outcome will not automatically help with another.

Taken together, these say more about whether a probiotic is likely to work than the CFU figure alone. For a broader foundation, see our guide to what makes a high-quality probiotic, and for how prebiotics and probiotics differ, see prebiotics vs probiotics.

The Bottom Line: Reading a Probiotic Label

A probiotic label is easier to judge once you stop reading it as a numbers contest. Rather than reaching for the highest CFU, look for a named strain down to the strain level, a dose you can match against research, clear storage and use-by information, and a delivery format suited to the strain. Your gut does not simply need more bacteria; it needs the right ones, kept viable and delivered sensibly. For the wider context, our gut health and microbiome hub ties these ideas together.

A Note on Next-Microbiome Products

Two Next-Microbiome formulas reflect this function-first approach. Akkermansia Chewable is a chewable Akkermansia muciniphila formula designed for oral and upper-tract interaction. Akkermansia is one of the more studied next-generation strains for gut-lining and metabolic research, and it is also notoriously difficult to culture, which is part of why counting methods beyond CFU are relevant for it.

Boost Synergy pairs Akkermansia muciniphila with Clostridium butyricum, a butyrate producer, alongside prebiotics and polyphenols. It is studied in the context of gut-barrier and metabolic signaling, including GLP-1-related pathways, though that evidence is mostly preclinical and early rather than a demonstrated hormone effect. Treat any supplement as a complement to diet and lifestyle, and check with a clinician if you are pregnant, nursing, managing a health condition, or taking medication.

Frequently Asked Questions About Probiotic CFU and Quality

1. What should I look for on a probiotic label besides CFU count?

A stronger label does more than list CFUs. Guidance from the NIH Office of Dietary Supplements and ISAPP suggests looking for the full organism name down to genus, species, and strain, plus a clear recommended use, serving size, storage instructions, and a use-by or expiration date. Different strains within the same species can have different functions, so the label should help you identify what you are actually taking.

2. Do storage instructions and expiration dates really matter?

Yes. Probiotics are living microorganisms, so storage and shelf life matter. Mayo Clinic Health System advises following storage instructions because some products need refrigeration, and ISAPP explains that probiotic numbers can drop during storage, which is why the use-by date matters. In practice, judge a probiotic by whether it stays viable through the labeled shelf life, not only by what was present at manufacture.

3. Are more probiotic strains always better than fewer?

Not always. The NIH notes that probiotic effects can be species-specific and strain-specific, Cleveland Clinic notes that different microbes function differently in the body, and Mayo Clinic Health System says there is no one-size-fits-all application, since each strain may perform a separate function. A formula with fewer well-chosen strains can be more meaningful than a longer label of poorly matched ones.

Scientific References:

1. Hill C, Guarner F, Reid G, et al.
   Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
   Nat Rev Gastroenterol Hepatol 2014;11(8):506-514 
   doi:10.1038/nrgastro.2014.66 (Expert consensus statement)

2. Davis C.
   Enumeration of probiotic strains: Review of culture-dependent and alternative techniques to quantify viable bacteria
   J Microbiol Methods 2014;103:9-17
   doi:10.1016/j.mimet.2014.04.012 (Peer-reviewed review)

3. National Institutes of Health, Office of Dietary Supplements
   Probiotics: Fact Sheet for Health Professionals (Authoritative guidance)

4. International Scientific Association for Probiotics and Prebiotics (ISAPP)
   How to read a probiotic label (Authoritative guidance)

Written by Ali Rıza Akın

Microbiome Scientist, Author & Founder of Next-Microbiome

Ali Rıza Akın is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation.

His work focuses on how microbial ecosystems interact with human physiology, including:

• Gut barrier function and intestinal permeability

• Mucus-associated microbiota (Akkermansia-related systems)

• Oral–gut microbiome axis

• Short-chain fatty acids (SCFAs) and metabolic signaling

• Circadian rhythm–microbiome interactions

• Clinical Research Contributions

He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including:

Active Ulcerative Colitis (Inflammatory Bowel Disease)

Hyperoxaluria (Oxalate Metabolism Disorder)

Microbiome-driven gut health and inflammatory conditions

These studies were part of broader clinical development programs evaluating microbiome-based approaches. His contributions focused on the early-stage scientific and translational pipeline, including strain discovery, functional optimization, and multi-strain formulation design.

Scientific Contributions:

Ali Rıza Akın is the discoverer of Christensenella californii, a bacterial species associated with microbiome diversity and metabolic health.

He is a contributing author to scientific publications and Bacterial Therapy of Cancer (Springer), and the author of Bakterin Kadar Yaşa: İçimizdeki Evren: Mikrobiyotamız.

Approach:

His work emphasizes evidence-based microbiome science, long-term safety, and a systems-based understanding of how microbes influence human health.

Review and Sources

This article is written and reviewed by a microbiome scientist and draws on the peer-reviewed and authoritative sources listed in the References. It describes how probiotics are measured and what to look for on a label, labels early and mechanistic evidence as such, and is reviewed periodically against current research.

Medical Disclaimer

This content is for educational and informational purposes only and is not medical advice, diagnosis, or treatment. Dietary supplements are not reviewed or approved by the US Food and Drug Administration for effectiveness before they are sold, are intended for adults, and are not a substitute for a balanced diet or prescribed treatment. Any GLP-1-related research described here is preliminary and does not mean a supplement acts like a medication. Consult a qualified healthcare professional before making changes to your diet, supplement routine, or treatment, especially if you are pregnant, nursing, immunocompromised, managing a health condition, or taking medication.

Last reviewed: August 2026